To Evaluate PK and Safety Profile of Oral MAD of Separately Using TG-2349, DAG181 or Combination in Healthy Chinese Volunteers
Clinical trial NCT03610880 · COMPLETED
Trial details
- NCT number
- NCT03610880
- Sponsor
- Dongguan HEC TaiGen Biopharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-17
- Primary completion
- 2018-02-05
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.